Intermediate for Idelalisib. Idelalisib (trade name Zydelig) is a phosphoinositide 3-kinase inhibitor for the treatment of certain hematological malignancies. Idelalisib has been approved by the U.S Food and Drug Administration on July 23, 2014.

Specifications

Product Name:                  6-Chloro-9-tetrahydro-2-pyranyl-purine

Synonyms:                         N/A

CAS Number:                     7306-68-5

Molecular Weight:            238.6761

Molecular Formula:          C10H11ClN4O

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               Clc1ncnc2c1ncn2C1CCCCO1